UBAC2
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1399912534rs3809367AGrs38093672.03E-04GEMCITABINE|CYTARABINEMANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINEResponse to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162AintronGWASdb_drug
1399959945rs1923891GArs19238914.87E-04GEMCITABINE|CYTARABINEMANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINEResponse to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162CintronGWASdb_drug
1399968512rs17472169AGrs174721698.97E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763AintronGWASdb_drug
13100005745rs17575699GArs175756992.00E-04TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561GintronGWASdb_drug
13100008313rs7993715CGrs79937157.86E-05GEMCITABINE|CYTARABINEMANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINEResponse to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162CintronGWASdb_drug
1399855124rs2182885GArs21828853.12E-05Self-reported allergyHPOID:0002715DOID:0060056GintronGWASdb_trait
1399869456rs7338177CTrs73381778.97E-05Self-reported allergyHPOID:0002715DOID:0060056CintronGWASdb_trait
1399870640rs731955TArs7319555.42E-05Self-reported allergyHPOID:0002715DOID:0060056AintronGWASdb_trait
1399876281rs9513584GArs95135845.00E-04Behcet's diseaseHPOID:0011955DOID:13241AintronGWASdb_trait
1399877471rs7332672CTrs73326729.55E-05Self-reported allergyHPOID:0002715DOID:0060056CintronGWASdb_trait
1399879496rs7322572CTrs73225729.18E-05Self-reported allergyHPOID:0002715DOID:0060056CintronGWASdb_trait
1399912534rs3809367AGrs38093672.03E-04Response to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162AintronGWASdb_trait
1399937082rs2182954CTrs21829547.03E-04Multiple complex diseasesHPOID:0000118NATintronGWASdb_trait
1399959945rs1923891GArs19238914.87E-04Response to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162CintronGWASdb_trait
1399968151rs9517683AGrs95176832.30E-05basal cell carcinomaHPOID:0002671DOID:2513AintronGWASdb_trait
1399968512rs17472169AGrs174721698.97E-04Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763AintronGWASdb_trait
1399984675rs17575643CTrs175756435.33E-04Multiple complex diseasesHPOID:0000118NATintronGWASdb_trait
13100004108rs727263GArs7272637.33E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
13100005745rs17575699GArs175756992.00E-04Cognitive impairment induced by topiramateHPOID:0100543DOID:1561GintronGWASdb_trait
13100008313rs7993715CGrs79937157.86E-05Response to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162CintronGWASdb_trait
13100023469rs7332161GArs73321619.16E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
13100029540rs9517701AGrs95177014.05E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
13100029932rs7325747CTrs73257476.29E-04Multiple complex diseasesHPOID:0000118NACintronGWASdb_trait
13100033652rs912129AGrs9121297.52E-04Multiple complex diseasesHPOID:0000118NATintronGWASdb_trait
13100033652rs912129AGrs9121296.60E-04Type 2 diabetes and 6 quantitative traitsHPOID:0005978DOID:9352TintronGWASdb_trait
13100033652rs912129AGrs9121294.40E-04Self-reported allergyHPOID:0002715DOID:0060056TintronGWASdb_trait
13100034116rs4772190AGrs47721909.37E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
13100038336rs1058143TCrs10581430.000027Primary sclerosing cholangitisHPOID:0001080DOID:14268TUTR-3GWASdb_trait